The New Scientist piece highlights clinician reports of incessant, hyper-vivid dreams producing next-day exhaustion, yet stops short of linking this to broader patterns of REM dysregulation seen in post-pandemic populations. Drawing on Schredl's 2022 longitudinal analysis in Journal of Sleep Research (n=1,248 participants tracked via daily dream logs over 6 months) and a 2023 Sleep Medicine Reviews synthesis of 17 studies on intense dreaming, the pattern emerges as tied to elevated cortisol and fragmented slow-wave sleep rather than isolated pathology. Original coverage overlooked medication interactions and social media's role in priming emotional dream content, factors evident in multiple cohorts. No large-scale epidemiological data yet supports formal disorder status; current evidence rests on case series and self-reports, limiting generalizability. This aligns with the observed shift where vivid intense dreams now drive measurable daytime fatigue and emotional strain, demanding refined polysomnography protocols beyond standard nightmare disorder criteria.